Better Diagnosis for Inflammatory Lung Diseases
Part of Lungs & breathing clinical trials.
This study tests new ways to manage inflammatory lung diseases by analyzing blood and saliva samples. It uses home monitoring devices to better understand your condition, which may help doctors tailor your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a doctor-confirmed diagnosis of COPD, IPF (a type of lung scarring), or CPFE (both scarring and emphysema).
- You must agree to give blood and saliva samples for research.
- You must be willing to use home monitoring devices (like air quality sensors or telemedicine tools).
- You must be able to attend all follow-up visits and follow the study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects airway samples (usually during a bronchoscopy), plus blood and/or urine, to help researchers study lung conditions. It may help advance understanding of lung disease and related biology, but it is not a treatment trial.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This trial is studying people with chronic lung conditions, like COPD or asthma, to find treatable traits. It also includes healthy volunteers for comparison, to better understand what makes these diseases different and how to personalize treatment.
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.